| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 10.968 | 44.743 | 45.248 | 53.881 | 68.002 | 64.935 | 79.921 | 92.604 | 106.310 | 121.862 |
| Total Income - EUR | 10.968 | 44.743 | 45.840 | 55.622 | 68.004 | 64.935 | 79.921 | 92.606 | 106.311 | 121.864 |
| Total Expenses - EUR | 3.503 | 42.635 | 35.965 | 34.456 | 36.820 | 35.803 | 35.119 | 36.705 | 42.216 | 53.614 |
| Gross Profit/Loss - EUR | 7.465 | 2.109 | 9.875 | 21.165 | 31.183 | 29.133 | 44.802 | 55.901 | 64.095 | 68.250 |
| Net Profit/Loss - EUR | 7.136 | 1.545 | 9.421 | 20.626 | 30.503 | 28.513 | 44.019 | 55.040 | 63.042 | 64.667 |
| Employees | 1 | 3 | 4 | 5 | 4 | 3 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Pelea Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 957 | 701 | 1.065 | 619 | 811 | 505 | 2.591 | 3.141 | 2.275 |
| Current Assets | 9.866 | 8.080 | 11.716 | 31.098 | 10.658 | 31.970 | 46.017 | 68.632 | 27.206 | 84.874 |
| Inventories | 88 | 1.072 | 1.588 | 1.111 | 0 | 0 | 1.721 | 0 | 0 | 256 |
| Receivables | 4.870 | 3.403 | 5.678 | 6.014 | 5.901 | 725 | 8.581 | 50.203 | 18.485 | 5.818 |
| Cash | 4.908 | 3.606 | 4.451 | 23.973 | 4.757 | 31.245 | 35.715 | 18.429 | 8.722 | 78.800 |
| Shareholders Funds | 7.181 | 1.598 | 9.482 | 29.934 | 7.951 | 30.655 | 44.076 | 55.097 | 14.173 | 64.715 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.685 | 7.439 | 2.935 | 2.229 | 3.326 | 2.126 | 2.447 | 16.126 | 16.174 | 22.434 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Pelea Med Srl